Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,525
Closed -$391K 1205
2025
Q4
$391K Buy
+1,525
New +$400K ﹤0.01% 929
2024
Q4
Sell
-4,011
Closed -$1.27M 938
2024
Q3
$1.27M Buy
+4,011
New +$1.43M 0.02% 428
2022
Q3
Sell
-1,361
Closed -$637K 561
2022
Q2
$637K Buy
1,361
+534
+65% +$238K 0.03% 349
2022
Q1
$360K Buy
827
+9
+1% +$3.77K 0.02% 341
2021
Q4
$379K Buy
818
+1
+0.1% +$443 0.02% 318
2021
Q3
$318K Buy
817
+2
+0.2% +$849 0.02% 242
2021
Q2
$361K Buy
815
+1
+0.1% +$437 0.03% 229
2021
Q1
$341K Buy
+814
New +$325K 0.03% 246

Other funds holding HUM

NewEdge Wealth's HUM Position: Q1 2026 in Review

NewEdge Wealth sold out of Humana (HUM) in Q1 2026, closing a stake of 1,525 shares — an estimated $391K sold.

NewEdge Wealth first reported a position in HUM in Q1 2021 and held it in 8 quarters. The position peaked at $1.27M in Q3 2024. 786 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • NewEdge Wealth reported no remaining Humana position as of Q1 2026 after selling out during the quarter.
  • NewEdge Wealth sold 1,525 Humana shares in Q1 2026, an estimated $391K.
  • NewEdge Wealth first reported a position in Humana in Q1 2021 and held it in 8 quarters.
  • NewEdge Wealth's Humana position peaked at $1.27M in Q3 2024.
  • 786 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on NewEdge Wealth's 13F filing for Q1 2026, filed 13 May 2026.